• HOME
  • ABOUT

    ABOUT

    • Profile
    • Honor
    • Development History
  • NEWS

    NEWS

    • Biotron news
    • Exhibition
  • PRODUCTS

    PRODUCTS

    • Molecular Diagnostics Platform
    • Immuno-POCT Platform
    • Pathology Diagnostics Platform
    • Oncology Liquid Biopsy Platform
    • Others
    • POCT series
    • STH-PAS method
    • Novel coronavirus (COVID-19) series
    • MORE
  • SOLUTIONS

    SOLUTIONS

    • Multiplex Probe Amplification
    • Chromatography Membrane Hybridization Method
  • CONTACT US
  • CNTR
  • Home
  • ABOUT
    Profile Honor Development History
  • NEWS
    Biotron news Exhibition
  • PRODUCTS
    Molecular Diagnostics Platform Immuno-POCT Platform Pathology Diagnostics Platform Oncology Liquid Biopsy Platform Others POCT series Molecular diagnostic series MPA method STH-PAS method Novel coronavirus (COVID-19) series MORE
  • SOLUTIONS
    Multiplex Probe Amplification Chromatography Membrane Hybridization Method
  • CONTACT US
  • CN
  • TR
Index > Product > Molecular Diagnostics Platform > Pharmacogenomics (PGx)

Human APOE Genotyping Detection Kit (Fluorescent PCR Enzyme Cut Method)

This kit is used for qualitative detection of APOE gene 6 genotypes in human whole blood DNA in vitro, namely ε2/ε2(rs429358T/T, rs7412T/T)、ε2/ε3(rs429358T/T, rs7412T/C)、ε3/ε3(rs429358T/T, rs7412C/C)、ε2/ε4(rs429358T/C, rs7412T/C)、ε3/ε4(rs429358T/C, rs7412C/C)和ε4/ε4(rs429358C/C, rs7412C/C).

Successfully obtained in the EU CE access certification.

Download Materials:
Online Preview Download

DESCRIPTION

Main clinical applications:

1.Disease risk prediction

Evaluate the risk of Alzheimer's disease, cardiovascular and cerebrovascular diseases, diabetes and other diseases, so as to carry out early prevention in a timely manner.

2.Health management

Predict the effect of fish oil supplementation, guide personal dietary habits: lipid intake and alcohol consumption recommendations;

3.Lipid-lowering drugs/lencanelizumab medication guidance

Guidance on the rational use of lipid-lowering statins, assessment of the side effects of the AD-targeted drug Lencanelizumab.


Applicable Instruments:

HONGSHI SLAN-96, ABI 7500,  and other four-channel fluorescence PCR instruments.


SPECIFICATION

1.High sensitivity

Unique nucleic acid invasion signal amplification technology, the lowest detection limit of 0.2 ng/μl.

2.Convenient operation

Full premixed reagents, ready to use, no need to dispense.

3.Setting internal standard

Prevent false negatives.

4.Automated result interpretation

Customized software algorithms, automatic interpretation of results


HOW CAN WE HELP?
Biotron is committed to quality customer service. If you have any question, please feel free to contact us.
Request
<
>
<
>
  • Product 分子诊断技术平台 POCT技术平台 病理诊断平台 肿瘤液体活检平台 其他 POCT series 隐藏 隐藏 STH-PAS method Novel coronavirus (COVID-19) series MORE
  • Scientific research Multiplex Probe Amplification Chromatography Membrane Hybridization Method
  • About Profile Honor Development History
  • News Biotron news Exhibition
  • Contact

    address:Room 301& 401, Building C6,No. 11 Kaiyuan Road, Huangpu District, Guangzhou,510530.P.R.China

    tel:020-32077730 32077731

    fax:020-32077729

    Email: overseas@ebiotron.com

友情链接 天极科技
版权所有@2020广州市宝创生物技术有限公司All Rights Resserved 粤ICP备2021003845号
网站地图技术支持: 天极科技
  • 返回顶部